Document ID: EPA-HQ-ORD-2019-0287-0001
Agency: epa
Document Type: Notice
Title: Availability of the Draft IRIS Toxicological Review of Perfluorodecanoic Acid [PFDA, CASRN 335–76–2] and Related Salts
Posted Date: 2023-04-10T04:00Z

[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Pages 21189-21190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07435]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-ORD-2019-0287; FRL-10829-01-ORD]

Availability of the Draft IRIS Toxicological Review of 
Perfluorodecanoic Acid [PFDA, CASRN 335-76-2] and Related Salts

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public comment period.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is announcing a 60-
day public comment period associated with release of the draft IRIS 
Toxicological Review of Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) 
and Related Salts. The draft document was prepared by the Center for 
Public Health and Environmental Assessment (CPHEA) within EPA's Office 
of Research and Development (ORD).
    EPA is releasing this draft IRIS assessment for public comment in 
advance of a contract-led peer review. Public comments received will be 
provided to the external peer reviewers. ERG, a contractor to EPA, will 
convene a public meeting to discuss the draft report with the public 
during Step 4 of the IRIS Process. The external peer reviewers will 
consider public comments submitted in response to this notice and 
comments provided at a future public peer review meeting. EPA will 
consider all comments received when revising the document post-peer 
review. This draft assessment is not final as described in EPA's 
information quality guidelines, and it does not represent, and should 
not be construed to represent Agency policy or views.

DATES: The 60-day public comment period begins April 10, 2023 and ends 
June 9, 2023. Comments must be received on or before June 9, 2023.

ADDRESSES: The IRIS Toxicological Review of Perfluorodecanoic Acid 
[PFDA, CASRN 335-76-2] and Related Salts will be available via the 
internet on the IRIS website at https://www.epa.gov/iris/iris-recent-additions and in the public docket at http://www.regulations.gov, 
Docket ID No. EPA-HQ-ORD-2019-0287.

FOR FURTHER INFORMATION CONTACT: For information on the public comment 
period, contact the ORD Docket at the EPA Headquarters Docket Center; 
telephone: 202-566-1752; facsimile: 202-566-9744; or email: 
[email protected].
    For technical information on the IRIS Toxicological Review of 
Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) and Related Salts, 
contact Dr. Andrew Kraft, CPHEA; telephone: 202-564-0286; or email: 
[email protected]. The IRIS Program will provide updates through the 
IRIS website (https://www.epa.gov/iris) and via EPA's IRIS listserv. To 
register for the IRIS listserv, visit the IRIS website (https://www.epa.gov/iris) or visit https://www.epa.gov/iris/forms/staying-connected-integrated-risk-information-system#connect.
    For questions about the peer review, please contact: Laurie Waite, 
ERG, by email at [email protected] (subject line: EPA PFAS assessments 
peer review); or by phone: (781) 674-7362.

SUPPLEMENTARY INFORMATION: 

How To Submit Technical Comments to the Docket at https://www.regulations.gov

    Submit your comments, identified by Docket ID No. EPA-HQ-ORD-2019-
0287 for the Perfluorodecanoic Acid IRIS Assessment, by one of the 
following methods:
     www.regulations.gov: Follow the on-line instructions for 
submitting comments.
     Email: [email protected].
     Fax: 202-566-9744.
     Mail: U.S. Environmental Protection Agency, EPA Docket 
Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW, 
Washington, DC 20460. The phone number is 202-566-1752.
    For information on visiting the EPA Docket Center Public Reading 
Room, visit https://www.epa.gov/dockets. Due to public health concerns 
related to COVID-19, the EPA Docket Center and Reading Room may be 
closed to the public with limited exceptions. The telephone number for 
the Public Reading Room is 202-566-1744. The public can submit comments 
via www.regulations.gov or email.
    Instructions: Direct your comments to docket number EPA-HQ-ORD-
2019-0287 for Perfluorodecanoic Acid IRIS Assessment.
    Please ensure that your comments are submitted within the specified 
comment period. Comments received after the closing date will be marked 
``late,'' and may only be considered if time permits. It is EPA's 
policy to include all comments it receives in the public docket without 
change and to make the comments available online at 
www.regulations.gov, including any personal information provided, 
unless a comment includes information claimed to be Confidential 
Business Information (CBI) or other information for which disclosure is 
restricted by statute. Do

[[Page 21190]]

not submit information through www.regulations.gov or email that you 
consider to be CBI or otherwise protected. The www.regulations.gov 
website is an ``anonymous access'' system, which means EPA will not 
know your identity or contact information unless you provide it in the 
body of your comment. If you send an email comment directly to EPA 
without going through www.regulations.gov, your email address will be 
automatically captured and included as part of the comment that is 
placed in the public docket and made available on the internet. If you 
submit an electronic comment, EPA recommends that you include your name 
and other contact information in the body of your comment and with any 
disk or CD-ROM you submit. If EPA cannot read your comment due to 
technical difficulties and cannot contact you for clarification, EPA 
may not be able to consider your comment. Electronic files should avoid 
the use of special characters, any form of encryption, and be free of 
any defects or viruses. For additional information about EPA's public 
docket visit the EPA Docket Center homepage at www.epa.gov/epahome/dockets.htm.
    Docket: Documents in the docket are listed in the 
www.regulations.gov index. Although listed in the index, some 
information is not publicly available, e.g., CBI or other information 
whose disclosure is restricted by statute. Certain other materials, 
such as copyrighted material, are publicly available only in hard copy. 
Publicly available docket materials are available either electronically 
in www.regulations.gov or in hard copy at the ORD Docket in the EPA 
Headquarters Docket Center.

Wayne Cascio,
Director, Center for Public Health & Environmental Assessment.
[FR Doc. 2023-07435 Filed 4-7-23; 8:45 am]
BILLING CODE 6560-50-P